Urinary Bisphenol a and type-2 diabetes in U.S. Adults: Data from NHANES 2003-2008

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Silver, Monica K ^a   O'Neill, Marie S ^a   Sowers, MaryFran R ^a   Park, Sung Kyun ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANTIDIABETIC AGENT; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; PHENOL DERIVATIVE;

ADULT; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG UTILIZATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISPANIC; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL RESEARCH; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; SOLID PHASE EXTRACTION; STATISTICAL SIGNIFICANCE; UNITED STATES; URINE LEVEL; ENVIRONMENTAL EXPOSURE; INSULIN RESISTANCE; NUTRITION; RISK; URINE;

DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL EXPOSURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; NUTRITION SURVEYS; ODDS RATIO; PHENOLS; PREVALENCE; UNITED STATES;

EID: 80055026254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026868     Document Type: Article

References (45)

1. Welshons WV, Nagel SC, vom Saal FS, (2006) Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147: S56-69.
2. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, et al. (2010) Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environmental Health Perspectives 118: 1055-1070.
3. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL, (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116: 39-44.
4. Nadal A, Alonso-Magdalena P, Soriano S, Ropero AB, Quesada I, (2009) The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 587: 5031-5037.
5. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB, (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304: 63-68.
6. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A, (2006) The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114: 106-112.
7. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, et al. (2008) Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 116: 1642-1647.
8. Ben-Jonathan N, Hugo ER, Brandebourg TD, (2009) Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 304: 49-54.
9. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, et al. (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300: 1303-1310.
10. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS, (2010) Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 5: e8673.
11. Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G, (1992) Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study. Journal of Epidemiology and Community Health 46: 537-542.
12. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, et al. (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clinical Trials 5: 240-247.
13. Espelt A, Goday A, Franch J, Borrell C, (2011) Validity of self-reported diabetes in health interview surveys for measuring social inequalities in the prevalence of diabetes. Journal of Epidemiology and Community Health.
14. Molenaar EA, Van Ameijden EJ, Grobbee DE, Numans ME, (2007) Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. European Journal of Public Health 17: 199-205.
15. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
16. Steenland K, Seals R, Klein M, Jinot J, Kahn HD, (2011) Risk estimation with epidemiologic data when response attenuates at high-exposure levels. Environmental Health Perspectives 119: 831-837.
17. National Center for Health Statistics (2004) National Health and Nutrition Examination Survey Data 2003-2004. Hyattsville, MD U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: National Center for Health Statistics.
18. National Center for Environmental Health (2005) NHANES 2003-2004 Laboratory Procedure Manual: Environmental Phenols. National Center for Environmental Health.
19. National Center for Environmental Health (2009) NHANES 2005-2006 Laboratory Procedure Manual: Environmental Phenols. National Center for Environmental Health.
20. National Center for Health Statistics (2010) 2005-2006 Data Documentation, Codebook, and Frequencies: Glycohemoglobin (GHB_D). National Center for Health Statistics.
21. National Center for Health Statistics (2009) 2007-2008 Data Documentation, Codebook, and Frequencies: Urinary Albumin and Urinary Creatinine (ALB_CR_E). National Center for Health Statistics.
22. National Center for Health Statistics (2006) NHANES Analytic and Reporting Guidlines. National Center for Health Statistics.
23. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, et al. (2005) Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113: 192-200.
24. Alonso-Magdalena P, Ropero AB, Soriano S, Quesada I, Nadal A, (2010) Bisphenol-A: a new diabetogenic factor? Hormones (Athens) 9: 118-126.
25. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ, (2009) Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ 339: b4432.
26. CDC, (2011) National Diabetes Fact Sheet. Centers for Disease Control and Prevention.
27. Mazurek JA, Hailpern SM, Goring T, Nordin C, (2010) Prevalence of Hemoglobin A1c Greater Than 6.5% and 7.0% among Hospitalized Patients without Known Diagnosis of Diabetes at an Urban Inner City Hospital. J Clin Endocrinol Metab.
28. Herman WH, Fajans SS, (2010) Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Pol Arch Med Wewn 120: 37-40.
29. Zirilli L, Rochira V, Diazzi C, Caffagni G, Carani C, (2008) Human models of aromatase deficiency. J Steroid Biochem Mol Biol 109: 212-218.
30. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS, (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97: 12729-12734.
31. Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychaleckyj JC, et al. (2007) Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study. Diabetes 56: 2135-2141.
32. Livingstone C, Collison M, (2002) Sex steroids and insulin resistance. Clin Sci (Lond) 102: 151-166.
33. Louet JF, LeMay C, Mauvais-Jarvis F, (2004) Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6: 180-185.
34. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, et al. (2008) Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 3: e2069.
35. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A, (2008) The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 73: 874-879.
36. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB, (2006) Adiponectin-a key adipokine in the metabolic syndrome. Diabetes, Obesity & Metabolism 8: 264-280.
37. Trujillo ME, Scherer PE, (2005) Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257: 167-175.
38. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV, (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24: 139-177.
39. Braun JM, Kalkbrenner AE, Calafat AM, Bernert JT, Ye X, et al. (2011) Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environmental Health Perspectives 119: 131-137.
40. Ye X, Wong LY, Bishop AM, Calafat AM, (2011) Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environmental Health Perspectives 119: 983-988.
41. Stahlhut RW, Welshons WV, Swan SH, (2009) Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect 117: 784-789.
42. Barker DJ, (1998) In utero programming of chronic disease. Clinical Science (Lond) 95: 115-128.
43. Barker DJ, Eriksson JG, Forsen T, Osmond C, (2002) Fetal origins of adult disease: strength of effects and biological basis. International Journal of Epidemiology 31: 1235-1239.
44. Tang WY, Ho SM, (2007) Epigenetic reprogramming and imprinting in origins of disease. Reviews in Endocrine & Metabolic Disorders 8: 173-182.
45. Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, et al. (2010) Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 118: 1243-1250.